Versant Venture Capital IV, L.P., 10% Owner at CRISPR Therapeutics AG (CRSP), bought 161,000 shares at $14.00 ($2.3M) on 2016-10-24, disclosed to the SEC on 2016-12-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.00 | 602 | $8K | 0.4% |
| 2 | $14.00 | 4,583 | $64K | 2.8% |
| 3 | $14.00 | 60,219 | $843K | 37.4% |
| 4 | $14.00 | 95,596 | $1.3M | 59.4% |
| Total | $14.00 avg | 161,000 | $2.3M | 100% |
| Filing → |